Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AnPac Bio-Medical Science Co., Ltd. (ANPC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2885-0.0063 (-2.14%)
At close: 04:00PM EDT
0.2830 -0.01 (-1.91%)
After hours: 07:58PM EDT
Advertisement

AnPac Bio-Medical Science Co., Ltd.

801 Bixing Street
Bihu County
Lishui 323006
China
86 57 8205 1666
https://www.anpacbio.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees86

Key Executives

NameTitlePayExercisedYear Born
Dr. Aidong ChenCEO & ChairmanN/AN/AN/A
Dr. Chris Chang YuCo-Founder & Head of China OperationsN/AN/A1959
Dr. He YuCo-Founder & Chief Medical OfficerN/AN/A1958
Mr. Jinqiu TangChief Financial OfficerN/AN/A1983
Dr. Sunil PanditU.S. Chief Exec. OfficerN/AN/AN/A
Mr. Weidong DaiChina PresN/AN/A1961
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China. It offers cancer differentiation analysis devices and physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

Corporate Governance

AnPac Bio-Medical Science Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement